Literature DB >> 32265096

miR-10b regulated by Twist maintains myofibroblasts activities in oral submucous fibrosis.

Chih-Yuan Fang1, Cheng-Chia Yu2, Yi-Wen Liao2, Pei-Ling Hsieh3, Yoichi Ohiro4, Pei-Ming Chu3, Yu-Cheng Huang5, Chuan-Hang Yu6, Lo-Lin Tsai7.   

Abstract

BACKGROUND/
PURPOSE: Oral submucous fibrosis (OSF) is an oral precancerous disorder associated with the habit of areca nut chewing. MiR-10b has been shown to be upregulated in the oral cancer cells and induced by Twist. Our previous work has revealed that Twist participated in the pathogenesis of OSF and therefore we aimed to investigate whether Twist/miR-10b axis was involved in the activation of myofibroblast in the oral cavity.
METHODS: The expression levels of miR-10b in OSF tissues and fibrotic buccal mucosal fibroblasts (fBMFs) were examined. Besides, the expression of miR-10b was determined in fBMFs following knockdown of Twist or in BMFs after arecoline stimulation. Myofibroblast activities, including collagen gel contraction, migration and wound healing abilities, as well as the expression of α-SMA were measured in fBMFs treated with miR-10b inhibitor. Last, we investigated whether the effect of Twist overexpression could be reversed by suppression of miR-10b.
RESULTS: MiR-10b expression was overexpressed in both OSF tissues and fBMFs. The silence of Twist resulted in the downregulation of miR-10b in fBMFs and arecoline treatment led to an increase of miR-10b in a dose-dependent manner. Inhibition of miR-10b ameliorated the activation of myofibroblasts and the expression of α-SMA. Moreover, we demonstrated that suppression of miR-10b hindered the increased collagen gel contraction caused by Twist overexpression.
CONCLUSION: MiR-10b upregulation in OSF may be due to the stimulation of areca nut, leading to elevated myofibroblast activation. Our findings showed that the areca nut-induced expression of miR-10b was under the regulation of Twist and inhibition of miR-10b may provide a direction for treatment of OSF.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  MicroRNA-10b; Myofibroblast; Oral submucous fibrosis; Twist

Mesh:

Substances:

Year:  2020        PMID: 32265096     DOI: 10.1016/j.jfma.2020.03.005

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  4 in total

1.  Knockdown of LncRNA NEAT1 inhibits myofibroblast activity in oral submucous fibrosis through miR-760/TPM1 axis.

Authors:  Wei Li; Bin Cheng
Journal:  J Dent Sci       Date:  2021-12-08       Impact factor: 3.719

Review 2.  The functional roles of microRNAs in the pathogenesis of oral submucous fibrosis.

Authors:  Pei-Ling Hsieh; Szu-Han Chen; Yu-Feng Huang; Ming-Yi Lu; Cheng-Chia Yu
Journal:  J Dent Sci       Date:  2021-08-01       Impact factor: 3.719

Review 3.  Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.

Authors:  Yen-Wen Shen; Yin-Hwa Shih; Lih-Jyh Fuh; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

Review 4.  Regional Diversities in Fibrogenesis Weighed as a Key Determinant for Atrial Arrhythmogenesis.

Authors:  Cheng-Chih Chung; Chye-Gen Chin; Yung-Kuo Lin; Yao-Chang Chen; Wan-Li Cheng; Yung-Hsin Yeh; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Biomedicines       Date:  2021-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.